InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Jones Erika, Autre. Director active across 1 company, notably Black Diamond Therapeutics, Inc.. Cumulatively, 3 filings have been logged. History available since 15 February 2022. The latest transaction was disclosed on 30 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Jones Erika
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
75,000 shares0Common StockSEC:0001415889-25-002489:0
5,075 shares0Common StockSEC:0001104659-23-022388:0
5,075 shares0Common StockSEC:0001415889-22-001515:0
3 of 3 declarations
About Jones Erika
Erika Jones is involved in various functions at Black Diamond Therapeutics, Inc. While the details of her role are not specified, she contributes to the company's mission in the biopharmaceutical sector. Her expertise is valuable for developing innovative solutions.
